# TSPAN32

## Overview
TSPAN32 is a gene that encodes the protein tetraspanin 32, a member of the tetraspanin family, which is characterized by its four transmembrane domains. Tetraspanin 32 is involved in various cellular processes, including cell adhesion, migration, and signal transduction, primarily within the immune system. It is predominantly expressed in lymphoid cells, where it plays a crucial role in regulating T cell activation and maintaining immune tolerance. The protein forms tetraspanin-enriched microdomains (TEMs) through interactions with other proteins, influencing cellular signaling pathways. TSPAN32 has been implicated in the suppression of certain leukemias and the modulation of immune responses, highlighting its significance in both cancer biology and autoimmune disease contexts (Zhang2024Tspan; Lombardo2019Modulation; Qiu2023TSPAN32).

## Structure
TSPAN32, a member of the tetraspanin family, is characterized by its four transmembrane domains, which are highly hydrophobic and conserved. These domains are linked by two extracellular loops: a small extracellular loop (EC1) between the first and second transmembrane domains, and a larger extracellular loop (EC2) between the third and fourth transmembrane domains. The EC2 loop is crucial for protein-protein interactions and proper folding, facilitated by disulfide bridges formed by cysteine residues (Zhang2024Tspan).

The protein also contains a small intracellular loop (SIL) between the second and third transmembrane segments, which features a conserved M-shaped motif. This motif includes a central polar residue, often an asparagine, which plays a significant role in maintaining the protein's structure (Reppert2022A). The cytoplasmic domains of TSPAN32 contain palmitoylation sites, which are important for its function (Zhang2024Tspan).

TSPAN32 forms tetraspanin-enriched microdomains (TEMs) through interactions with other proteins, influencing various cellular activities and signaling pathways (Zhang2024Tspan). While specific details about the quaternary structure of TSPAN32 are not provided, its role in forming complexes with other proteins suggests a significant structural and functional complexity.

## Function
TSPAN32, or tetraspanin 32, is a member of the tetraspanin family of proteins, which are involved in various cellular processes such as cell adhesion, migration, and signal transduction. In healthy human cells, TSPAN32 is primarily expressed in the lymphoid lineage, with higher levels in na√Øve T helper cells compared to cytotoxic T cells (Lombardo2019Modulation). TSPAN32 plays a role in regulating T cell activation and proliferation. It acts as a regulatory brake on T cell activation, helping to maintain immune tolerance by modulating the expression of other tetraspanins such as CD63 and TSPAN7 (Lombardo2019Modulation). 

The expression of TSPAN32 is downregulated upon T cell activation, particularly in T helper cells when stimulated via CD3/CD28, although this downregulation is not observed in regulatory T cells (Lombardo2019Modulation). The modulation of TSPAN32 expression is linked to the mTOR pathway, which is activated upon T cell stimulation (Lombardo2019Modulation). TSPAN32 is also involved in the negative regulation of peripheral T-lymphocyte activation, as evidenced by hyperproliferative T cells in TSPAN32 knockout models (Lombardo2019Modulation).

## Clinical Significance
Alterations in the expression of the TSPAN32 gene have been implicated in several diseases, particularly in the context of leukemia and autoimmune disorders. In chronic myeloid leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL), TSPAN32 acts as a tumor suppressor by stabilizing the PTEN protein, which represses the PI3K-AKT signaling pathway. High expression of TSPAN32 is associated with better survival outcomes in Philadelphia chromosome-positive (Ph+) B-ALL patients, suggesting its potential as a prognostic marker. Conversely, decreased expression of TSPAN32, often due to repression by the BCR-ABL fusion gene, is linked to disease progression and resistance to tyrosine kinase inhibitors like Imatinib (Qiu2023TSPAN32).

In the context of autoimmune diseases such as multiple sclerosis (MS), TSPAN32 appears to play a regulatory role in T cell-mediated immune responses. Lower levels of TSPAN32 are observed in encephalitogenic T cells from experimental autoimmune encephalomyelitis (EAE) mice, a model for MS, and in activated CD4 T cells from MS patients. This reduction is associated with increased T cell activity and elevated pro-inflammatory cytokines, suggesting that TSPAN32 may help maintain immune tolerance and its downregulation could contribute to the pathogenesis of MS (Lombardo2019Modulation).

## Interactions
TSPAN32, also known as tetraspanin 32, is involved in several protein interactions that influence its function in cellular processes. It has been shown to interact with PTEN, a tumor suppressor protein, stabilizing it and thereby reducing the activity of the PI3K-AKT signaling pathway. This interaction is crucial in suppressing the pathogenesis and progression of chronic myeloid leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL) (Qiu2023TSPAN32). The interaction between TSPAN32 and PTEN was confirmed through co-immunoprecipitation assays, indicating a direct physical association (Qiu2023TSPAN32).

TSPAN32 is also predicted to interact with other tetraspanins, such as CD63 and TSPAN7, suggesting a regulatory network involving these proteins. These interactions may play a role in modulating immune responses, particularly in the context of multiple sclerosis (MS) (Lombardo2019Modulation). The transcription factor TAL1 has been identified as a regulator of TSPAN32 expression, with high TAL1 levels leading to increased TSPAN32 mRNA and protein levels, further influencing its interactions and functions (Qiu2023TSPAN32). These interactions highlight the multifaceted role of TSPAN32 in both immune regulation and cancer suppression.


## References


[1. (Zhang2024Tspan) Huhu Zhang, Qinghang Song, Kaiwen Shang, Ya Li, Liangqian Jiang, and Lina Yang. Tspan protein family: focusing on the occurrence, progression, and treatment of cancer. Cell Death Discovery, April 2024. URL: http://dx.doi.org/10.1038/s41420-024-01961-0, doi:10.1038/s41420-024-01961-0. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-024-01961-0)

[2. (Reppert2022A) Nikolas Reppert and Thorsten Lang. A conserved sequence in the small intracellular loop of tetraspanins forms an m-shaped inter-helix turn. Scientific Reports, March 2022. URL: http://dx.doi.org/10.1038/s41598-022-07243-y, doi:10.1038/s41598-022-07243-y. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-07243-y)

[3. (Lombardo2019Modulation) Salvo Danilo Lombardo, Emanuela Mazzon, Maria Sofia Basile, Giorgia Campo, Federica Corsico, Mario Presti, Placido Bramanti, Katia Mangano, Maria Cristina Petralia, Ferdinando Nicoletti, and Paolo Fagone. Modulation of tetraspanin 32 (tspan32) expression in t cell-mediated immune responses and in multiple sclerosis. International Journal of Molecular Sciences, 20(18):4323, September 2019. URL: http://dx.doi.org/10.3390/ijms20184323, doi:10.3390/ijms20184323. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20184323)

[4. (Qiu2023TSPAN32) Qiang Qiu, Yuanyuan Sun, Linyu Yang, Qingqing Li, Yunyu Feng, Mengyuan Li, Yuexia Yin, Li Zheng, Ning Li, Huandi Qiu, Xue Cui, Wei He, Bochuan Wang, Cong Pan, Zi Wang, Juan Huang, Klarke M. Sample, Zhihui Li, and Yiguo Hu. Tspan32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing pten. Signal Transduction and Targeted Therapy, March 2023. URL: http://dx.doi.org/10.1038/s41392-022-01290-7, doi:10.1038/s41392-022-01290-7. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41392-022-01290-7)